DRUGS & AGING

Scope & Guideline

Elevating standards in geriatric medication management.

Introduction

Delve into the academic richness of DRUGS & AGING with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1170-229x
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1991 to 2024
AbbreviationDRUG AGING / Drugs Aging
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The journal 'DRUGS & AGING' aims to address the complex pharmacotherapy needs of older adults, focusing on optimizing medication use while minimizing potential adverse effects. Its scope encompasses various aspects of drug therapy in geriatric populations, emphasizing evidence-based practices and interdisciplinary approaches.
  1. Geriatric Pharmacotherapy:
    Research dedicated to understanding the pharmacokinetics and pharmacodynamics of drugs in older adults, including how aging affects drug metabolism and response.
  2. Polypharmacy and Deprescribing:
    Focused studies on the prevalence and effects of polypharmacy in older adults, including strategies for deprescribing potentially inappropriate medications to improve patient outcomes.
  3. Chronic Disease Management:
    Investigations into the management of chronic conditions prevalent among older adults, such as diabetes, hypertension, and cardiovascular diseases, with an emphasis on tailored pharmacological interventions.
  4. Adverse Drug Reactions and Drug Interactions:
    Research aimed at identifying and mitigating adverse drug reactions and interactions, especially in the context of multimorbidity and polypharmacy.
  5. Quality of Life and Patient-Centered Care:
    Studies that explore the impact of pharmacotherapy on the quality of life, emphasizing patient perspectives and outcomes in the context of aging.
  6. Innovative Therapeutics:
    Research into newer therapeutic agents and treatment modalities, including biologics and targeted therapies, specifically for older populations.
The landscape of research within 'DRUGS & AGING' is dynamic, with several emerging themes reflecting current clinical challenges and innovations in geriatric pharmacotherapy.
  1. Digital Health and Telemedicine:
    An increasing number of studies are focusing on the role of digital tools and telemedicine in managing medications and health outcomes for older adults, highlighting the need for innovative approaches in a rapidly changing healthcare environment.
  2. Patient-Reported Outcomes and Quality of Life:
    There is a growing emphasis on incorporating patient-reported outcomes in research, reflecting a trend towards more holistic approaches to treatment that prioritize the patient's perspective on their health and medication.
  3. Pharmacogenomics in Aging:
    Emerging interest in pharmacogenomic studies to personalize medication regimens for older adults, aiming to optimize therapeutic efficacy while minimizing adverse effects.
  4. Use of Cannabis and Cannabinoids:
    Research on the use of medical cannabis and cannabinoids among older adults is gaining traction, particularly in relation to pain management and quality of life improvements.
  5. Focus on Frailty and Comprehensive Geriatric Assessment:
    An increasing number of studies are honing in on frailty as a critical factor in medication management, advocating for comprehensive geriatric assessments to tailor pharmacological treatments.

Declining or Waning

As the journal 'DRUGS & AGING' evolves, certain research themes appear to be declining in prominence. This may reflect shifts in clinical priorities, emerging evidence, or changing healthcare landscapes affecting older adults.
  1. Anticholinergic Burden Studies:
    While still relevant, there has been a noticeable decrease in dedicated studies focusing solely on anticholinergic burden, suggesting a potential shift towards broader polypharmacy and deprescribing discussions.
  2. Traditional Pain Management Approaches:
    Research centered around traditional pain management strategies, particularly opioid use, has seen reduced focus, likely due to increasing scrutiny over opioid prescribing and a shift towards non-pharmacological management.
  3. Longitudinal Studies of Aging and Medication Use:
    Fewer long-term studies tracking medication use and outcomes in aging populations indicate a potential waning interest in longitudinal methodologies in favor of more immediate, intervention-focused research.

Similar Journals

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Advancing Geriatric Medicine for a Healthier Tomorrow
Publisher: WILEYISSN: 0002-8614Frequency: 12 issues/year

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, published by Wiley, stands as a leading resource in the field of geriatrics and gerontology. Established in 1953 and converging into a comprehensive academic platform through 2024, this esteemed journal is recognized for its high impact, holding a Q1 ranking in its category for 2023. It serves as a vital conduit for innovative research, clinical practices, and policy discussions aimed at improving the health and well-being of older adults. With a commitment to advancing geriatric medicine, the journal contributes significantly to the ongoing dialogue among researchers, healthcare professionals, and students dedicated to this rapidly evolving field. Although currently not offering open access options, the journal remains invaluable for those seeking to access pivotal studies and reviews that shape the future of geriatrics.

Journal of Frailty & Aging

Fostering innovation in the study of frailty.
Publisher: SPRINGER BASEL AGISSN: 2260-1341Frequency: 4 issues/year

Journal of Frailty & Aging, published by SPRINGER BASEL AG, is a leading platform dedicated to advancing research in the fields of aging, geriatrics, and gerontology. With an ISSN of 2260-1341 and an E-ISSN of 2273-4309, this journal has established itself as a pivotal resource for scholars and practitioners aiming to explore the complexities of frailty and its impact on aging populations. As of 2023, it proudly holds a Q3 classification in Aging and Q2 classifications in both Geriatrics and Gerontology, as well as Physiology (medical), alongside a notable Q1 ranking in Medicine (miscellaneous). The journal's Scopus ranks further reflect its quality and relevance, with rankings as high as #22 in Aging within the Biochemistry, Genetics and Molecular Biology category. The Journal of Frailty & Aging invites contributions that illuminate contemporary challenges and innovations in the field, offering Open Access to enhance the dissemination of knowledge. By publishing rigorous research and impactful reviews, the journal strives to foster a deeper understanding of health and well-being in older adults, making it an essential resource for researchers, healthcare professionals, and students engaged in this vital area of study.

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement

Unraveling the Complexities of Aging with Expert Research
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 2115-8789Frequency: 4 issues/year

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement is a pivotal academic journal dedicated to the multidisciplinary study of aging, encompassing the fields of geriatrics, neuropsychiatry, and psychological health in the elderly population. Published by JOHN LIBBEY EUROTEXT LTD, this journal fosters knowledge dissemination and innovation, contributing to the understanding of the complexities faced by aging individuals. With a broad scope that includes biological psychiatry and neuropsychology, it serves as a vital resource for researchers, healthcare professionals, and students engaged in geriatric medicine and mental health. Although currently classified in the Q4 category across various relevant medical and psychological disciplines, the journal addresses critical topics that are essential for enhancing quality of care and improving patient outcomes. Additionally, the journal is accessible via open access options, promoting wide-ranging readership and collaboration within the academic community. As the field continuously evolves, Geriatrie et Psychologie Neuropsychiatrie du Vieillissement remains commited to pushing the boundaries of research and practice in gerontology and neuropsychiatry.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Navigating the Complexities of Drug Action and Toxicity
Publisher: WILEYISSN: 1742-7835Frequency: 12 issues/year

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

ACTA PHARMACEUTICA

Unlocking the potential of pharmaceutical research for all.
Publisher: SCIENDOISSN: 1330-0075Frequency: 4 issues/year

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

Geriatrics & Gerontology International

Fostering Collaboration in Geriatrics and Gerontology
Publisher: WILEYISSN: 1444-1586Frequency: 12 issues/year

Geriatrics & Gerontology International, published by WILEY, is a prestigious academic journal dedicated to advancing the field of geriatric and gerontological research. With a strong focus on the interdisciplinary aspects of aging, this journal has established itself as a leading source of high-quality research, reflected in its impressive impact factor and 2023 Scopus rankings, including a Q1 status in Health (Social Science) and Q2 in both Geriatrics and Gerontology. Since its inception in 2004 and continuous publication from 2008 to 2024, it has fostered a vibrant exchange of ideas among researchers, clinicians, and students alike. The journal serves as a critical resource for innovative studies, reviews, and commentaries that help shape policies and practices affecting the elderly population. It is essential reading for those dedicated to improving the quality of life for older adults and contributes significantly to the understanding of the complexities surrounding aging.

Journal of Gerontology and Geriatrics

Exploring the Complexities of Aging
Publisher: PACINI EDITOREISSN: 2499-6564Frequency: 4 issues/year

Journal of Gerontology and Geriatrics, published by PACINI EDITORE, is a crucial resource for those dedicated to the study of aging and geriatric health. Since its inception in 2016, this journal has aimed to disseminate high-quality research and findings that address the intricate biological, social, and psychological aspects of aging. With ISSN 2499-6564 and E-ISSN 2499-6564, it strives to foster discussions that enhance our understanding of gerontology and geriatrics on a global scale, despite its current positioning in the Q4 quartile of academic rankings. Located in Pisa, Italy, the journal invites contributions from researchers, professionals, and students who are passionate about advancing knowledge in these critical fields. Although it currently does not offer open access, the journal plays a vital role in connecting the community with essential insights that guide both research and practice in geriatric care.

Advances in Gerontology

Fostering Insights into Aging Dynamics
Publisher: PLEIADES PUBLISHING INCISSN: 2079-0570Frequency: 4 issues/year

Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

Drug Healthcare and Patient Safety

Prioritizing patient safety through impactful research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1365Frequency: 1 issue/year

Drug Healthcare and Patient Safety is a premier Open Access journal, published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the understanding and practices surrounding medication safety and healthcare delivery. With its ISSN 1179-1365 and E-ISSN matching, this New Zealand-based journal not only fosters global discourse but also prioritizes the dissemination of research that intersects both health policy and pharmacology. Categorized as Q2 in Health Policy and Q3 in Pharmacology for the year 2023, it occupies a notable position within the academic community, as reflected by its Scopus rankings, which place it in the 66th and 45th percentiles of its respective categories. Drug Healthcare and Patient Safety aims to provide a platform for researchers, practitioners, and students to share innovative findings, promote safe medication practices, and explore the implications of health policy on patient outcomes. As an Open Access journal, it ensures that vital research is accessible to a wider audience, making significant contributions to the ongoing dialogue in the fields of healthcare and pharmacovigilance.

AGE AND AGEING

Transforming Knowledge into Practice
Publisher: OXFORD UNIV PRESSISSN: 0002-0729Frequency: 6 issues/year

AGE AND AGEING is a premier peer-reviewed journal published by Oxford University Press, dedicated to advancing the field of gerontology and related medical disciplines. With its ISSN of 0002-0729 and E-ISSN 1468-2834, the journal has established itself as a critical platform for disseminating innovative research since its inception in 1972. It boasts impressive rankings within the Q1 category in Aging, Geriatrics and Gerontology, and Miscellaneous Medicine, reflecting its influential position in the scientific community. Researchers and practitioners alike value the journal's focus on the clinical, biological, and social aspects of aging, providing a multidisciplinary approach essential for addressing the challenges of an aging population. The journal maintains a significant impact factor, demonstrating its contribution to scholarly communication and knowledge dissemination. Although it does not operate under an open access model, AGE AND AGEING remains an essential resource for those committed to understanding the complexities of aging and enhancing the quality of life for older adults.